2024 Vol.42, N°12 - Table of contents
December - Sjögren’s syndrome 2024
Meeting Report
CER18181
2024,42,12
Pg. 2319-2321
Free to view
Highlights of the 16th International Symposium for Sjögren’s Disease
G.M. Verstappen, S. Pringle, H. Bootsma
Egmond aan Zee, the Netherlands, 22-25 April 2024
DOI: https://doi.org/10.55563/clinexprheumatol/60y54f
G.M. Verstappen, S. Pringle, H. Bootsma
Egmond aan Zee, the Netherlands, 22-25 April 2024
DOI: https://doi.org/10.55563/clinexprheumatol/60y54f
One year in review
CER18190
2024,42,12
Pg. 2322-2335
Free to view
Clinical manifestations, imaging and treatment of Sjögren’s disease: one year in review 2024
F. Tromby, V. Manfrè, L.G. Chatzis, S. Arends, A.G. Tzioufas, H. Bootsma, L. Quartuccio, E. Bartoloni
DOI: https://doi.org/10.55563/clinexprheumatol/5xq3fb
F. Tromby, V. Manfrè, L.G. Chatzis, S. Arends, A.G. Tzioufas, H. Bootsma, L. Quartuccio, E. Bartoloni
DOI: https://doi.org/10.55563/clinexprheumatol/5xq3fb
CER18373
2024,42,12
Pg. 2336-2343
Free to view
Pathogenesis of Sjögren’s disease: one year in review 2024
C. Baldini, L.G. Chatzis, G. Fulvio, G. La Rocca, E. Pontarini, M. Bombardieri
DOI: https://doi.org/10.55563/clinexprheumatol/i8iszc
C. Baldini, L.G. Chatzis, G. Fulvio, G. La Rocca, E. Pontarini, M. Bombardieri
DOI: https://doi.org/10.55563/clinexprheumatol/i8iszc
Editorial
CER17382
2024,42,12
Pg. 2344-2345
Free to view
Outcome measure in childhood Sjögren’s disease: where do we stand?
E. Marrani, V. Maniscalco, C. Baldini, G. Simonini
DOI: https://doi.org/10.55563/clinexprheumatol/faykmn
E. Marrani, V. Maniscalco, C. Baldini, G. Simonini
DOI: https://doi.org/10.55563/clinexprheumatol/faykmn
Environmental Rheumatology
CER17914
2024,42,12
Pg. 2346-2356
Free to view
The effect of smoking on Sjögren’s disease development and severity: a comprehensive literature review
M. Bandeira, B.A. Fisher
DOI: https://doi.org/10.55563/clinexprheumatol/efbdo3
M. Bandeira, B.A. Fisher
DOI: https://doi.org/10.55563/clinexprheumatol/efbdo3
CER17976
2024,42,12
Pg. 2357-2361
Free to view
Occupational, smoking and biomass fuel exposure in a cohort of Mexican patients with IgG4-related disease.
E. Martín-Nares, M. Gamboa-Espíndola, G. Hernández-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/163s3t
E. Martín-Nares, M. Gamboa-Espíndola, G. Hernández-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/163s3t
Full Papers
CER17409
2024,42,12
Pg. 2362-2368
Free to view
Abatacept use for 24 weeks has a limited effect on salivary gland inflammation in Sjögren’s disease patients
U. Nakshbandi, S.C. Liefers, S. Arends, F.K. Spijkervet, G.M. Verstappen, A. Vissink, L. De Wolff, B. Van Der Vegt, H. Bootsma, F.G. Kroese
DOI: https://doi.org/10.55563/clinexprheumatol/6n0y0v
U. Nakshbandi, S.C. Liefers, S. Arends, F.K. Spijkervet, G.M. Verstappen, A. Vissink, L. De Wolff, B. Van Der Vegt, H. Bootsma, F.G. Kroese
DOI: https://doi.org/10.55563/clinexprheumatol/6n0y0v
CER17188
2024,42,12
Pg. 2369-2377
Free to view
The role of imbalanced CD226/TIGIT on activated peripheral double-negative T cells in the pathogenesis of primary Sjögren's syndrome
C. Deng, A. Wang, W. Li, Y. Chen, R. Li, L. Zhao, J. Zhou, W. Zhang, M. Li, Y. Zhao, X. Zeng, Y. Fei
DOI: https://doi.org/10.55563/clinexprheumatol/yb63g0
C. Deng, A. Wang, W. Li, Y. Chen, R. Li, L. Zhao, J. Zhou, W. Zhang, M. Li, Y. Zhao, X. Zeng, Y. Fei
DOI: https://doi.org/10.55563/clinexprheumatol/yb63g0
CER17476
2024,42,12
Pg. 2378-2386
Free to view
Influence of doctor-patient relationships and health-related factors on the medical satisfaction of patients with Sjögren’s disease
K. Komori, M. Komori, T. Horino, S. Nishiyama, M. Takei, N. Suganuma
DOI: https://doi.org/10.55563/clinexprheumatol/4x0ntt
K. Komori, M. Komori, T. Horino, S. Nishiyama, M. Takei, N. Suganuma
DOI: https://doi.org/10.55563/clinexprheumatol/4x0ntt
CER17625
2024,42,12
Pg. 2387-2392
Free to view
The impact of two different rituximab-based strategies in cryoglobulinaemic vasculitis secondary to Sjögren’s disease: a monocentric cohort study
S. Longhino, E. Treppo, V. Manfrè, M. De Martino, M.T. Rizzo, M. Isola, S. De Vita, L. Quartuccio
DOI: https://doi.org/10.55563/clinexprheumatol/gakvbr
S. Longhino, E. Treppo, V. Manfrè, M. De Martino, M.T. Rizzo, M. Isola, S. De Vita, L. Quartuccio
DOI: https://doi.org/10.55563/clinexprheumatol/gakvbr
CER17465
2024,42,12
Pg. 2393-2403
Free to view
Investigation of pyroptosis-related hub genes and the immune microenvironment in primary Sjögren's syndrome
W. Chen, W. Chen, N. Xia, R. Yan
DOI: https://doi.org/10.55563/clinexprheumatol/3yu7pd
W. Chen, W. Chen, N. Xia, R. Yan
DOI: https://doi.org/10.55563/clinexprheumatol/3yu7pd
CER17688
2024,42,12
Pg. 2404-2411
Free to view
Implications of thyroid-related autoantibodies in patients with Sjögren’s syndrome without overt thyroid diseases
Y.-J. Ha, J.-I. Lee, S.R. Choi, E.H. Kang, K.-S. Kim, W.-J. Jeong, J.Y. Hyon, M.J. Kim, S. Cha, Y.J. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/b3035x
Y.-J. Ha, J.-I. Lee, S.R. Choi, E.H. Kang, K.-S. Kim, W.-J. Jeong, J.Y. Hyon, M.J. Kim, S. Cha, Y.J. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/b3035x
CER17590
2024,42,12
Pg. 2412-2419
Free to view
The abnormal expression of peripheral blood CD4+ T lymphocyte subsets are correlated with primary Sjögren’s syndrome complicated with haematological involvement
X. Li, S. Zhang, T. Cheng, J. Wang, F. Li, L. Shi, X. Li
DOI: https://doi.org/10.55563/clinexprheumatol/st9u8m
X. Li, S. Zhang, T. Cheng, J. Wang, F. Li, L. Shi, X. Li
DOI: https://doi.org/10.55563/clinexprheumatol/st9u8m
CER17751
2024,42,12
Pg. 2420-2426
Free to view
Anti-aquaporin-5 and anti-poly-U-binding-factor-60kDa protein antibodies in primary Sjögren's disease patients: preliminary data and correlation with disease activity indices
S. Stano, F. Cacciapaglia, A. Rinaldi, M. Giannotta, E. Urgesi, D. Natuzzi, F. Iannone
DOI: https://doi.org/10.55563/clinexprheumatol/ku7y1q
S. Stano, F. Cacciapaglia, A. Rinaldi, M. Giannotta, E. Urgesi, D. Natuzzi, F. Iannone
DOI: https://doi.org/10.55563/clinexprheumatol/ku7y1q
CER17988
2024,42,12
Pg. 2427-2436
Free to view
Efficacy of N-acetylcysteine for treating dryness symptoms of Sjögren’s disease: randomised placebo-controlled double-blind clinical study
J. D'agostino Gennari, G.B. Deveza, C.T. Ribeiro, A.C. Seguro, N.E. Aikawa, M.H.M. Shimizu, E.P. Leon, L.K. Guedes, L.V. Kupa, C.A. Silva, E. Bonfa, S.G. Pasoto
DOI: https://doi.org/10.55563/clinexprheumatol/dmd5dv
J. D'agostino Gennari, G.B. Deveza, C.T. Ribeiro, A.C. Seguro, N.E. Aikawa, M.H.M. Shimizu, E.P. Leon, L.K. Guedes, L.V. Kupa, C.A. Silva, E. Bonfa, S.G. Pasoto
DOI: https://doi.org/10.55563/clinexprheumatol/dmd5dv
CER18197
2024,42,12
Pg. 2437-2443
Free to view
Tofacitinib alleviated salivary gland inflammation and reduced the percentages of effector T cells in murine Sjögren’s disease
Q. Liu, X. Xing, J. He
DOI: https://doi.org/10.55563/clinexprheumatol/b91fx8
Q. Liu, X. Xing, J. He
DOI: https://doi.org/10.55563/clinexprheumatol/b91fx8
CER18027
2024,42,12
Pg. 2444-2452
Free to view
Impact of time to diagnosis in patients with primary Sjögren's syndrome: a cross-sectional study
A. Meinecke, K. Kreis, P. Olson, J.R. Hoeper, F. Engelke, T. Seeliger, T. Skripuletz, D. Ernst, K. Hoeper, T. Witte
DOI: https://doi.org/10.55563/clinexprheumatol/karr2a
A. Meinecke, K. Kreis, P. Olson, J.R. Hoeper, F. Engelke, T. Seeliger, T. Skripuletz, D. Ernst, K. Hoeper, T. Witte
DOI: https://doi.org/10.55563/clinexprheumatol/karr2a
CER18186
2024,42,12
Pg. 2453-2458
Free to view
Sjögren’s disease and systemic lupus erythematosus overlap syndrome as distinct entity at crossroads of two autoimmune disorders: clinical characterisation from two Italian reference centres for both the diseases
G. De Marchi, A. Nano, G. Fulvio, V. Manfrè, I.C. Navarro Garcia, A. Zabotti, E. Treppo, C. Baldini, L. Quartuccio, S. De Vita
DOI: https://doi.org/10.55563/clinexprheumatol/7v6qht
G. De Marchi, A. Nano, G. Fulvio, V. Manfrè, I.C. Navarro Garcia, A. Zabotti, E. Treppo, C. Baldini, L. Quartuccio, S. De Vita
DOI: https://doi.org/10.55563/clinexprheumatol/7v6qht
CER17882
2024,42,12
Pg. 2459-2467
Free to view
Reduced Deltex1 expression in T cells indicates increased disease activity in Sjögren’s disease
H.-C. Tsai, H.-T. Liao, W.-S. Chen, C.-C. Lai, Y.-S. Sun, T.-S. Hsu, M.-H. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/rtj93o
H.-C. Tsai, H.-T. Liao, W.-S. Chen, C.-C. Lai, Y.-S. Sun, T.-S. Hsu, M.-H. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/rtj93o
CER18140
2024,42,12
Pg. 2468-2475
Free to view
Field testing and clinical validation of the mSQUASH to measure physical activity in patients with Sjögren’s disease
N.S. Ausma, Y.M. Van Der Kraan, L. De Wolff, H. Kokol, M.J. Carbo, S.C. Kieskamp, D. Paap, A. Spoorenberg, H. Bootsma, S. Arends
DOI: https://doi.org/10.55563/clinexprheumatol/lcbs9m
N.S. Ausma, Y.M. Van Der Kraan, L. De Wolff, H. Kokol, M.J. Carbo, S.C. Kieskamp, D. Paap, A. Spoorenberg, H. Bootsma, S. Arends
DOI: https://doi.org/10.55563/clinexprheumatol/lcbs9m
CER18130
2024,42,12
Pg. 2476-2482
Free to view
Reliability of colour Doppler ultrasonography of the major salivary glands in Sjögren's disease
N.R. Sluijpers, M. Fadhil, A.J. Stel, P.U. Dijkstra, F.K. Spijkervet, S. Arends, H. Bootsma, A. Vissink, K. Delli
DOI: https://doi.org/10.55563/clinexprheumatol/ku5evp
N.R. Sluijpers, M. Fadhil, A.J. Stel, P.U. Dijkstra, F.K. Spijkervet, S. Arends, H. Bootsma, A. Vissink, K. Delli
DOI: https://doi.org/10.55563/clinexprheumatol/ku5evp
CER18203
2024,42,12
Pg. 2483-2489
Free to view
Ultrasonographic scores and parotid histopathology in Sjögren’s disease: challenges in lymphoma identification
I. Giovannini, M. De Martino, V. Manfrè, M. Lorenzon, L. Cereser, C. Di Loreto, C. Fabro, E. Pegolo, A. Zabotti, L. Quartuccio
DOI: https://doi.org/10.55563/clinexprheumatol/98vjav
I. Giovannini, M. De Martino, V. Manfrè, M. Lorenzon, L. Cereser, C. Di Loreto, C. Fabro, E. Pegolo, A. Zabotti, L. Quartuccio
DOI: https://doi.org/10.55563/clinexprheumatol/98vjav
CER18261
2024,42,12
Pg. 2490-2498
Free to view
Pilocarpine treatment of Sjögren’s syndrome curative effect of meta-analysis of randomised controlled trials
J. Wu, D. Li
DOI: https://doi.org/10.55563/clinexprheumatol/lkk9qq
J. Wu, D. Li
DOI: https://doi.org/10.55563/clinexprheumatol/lkk9qq
CER18201
2024,42,12
Pg. 2499-2506
Free to view
Non-negligible prevalence of focal lymphocytic sialadenitis in minor salivary glands of non-Sjögren's disease individuals
S. Liu, C. Chen, Q. Zheng, H. Sun, C. Yang, B. Wang, G. Shi, D. Xu, M. Shen
DOI: https://doi.org/10.55563/clinexprheumatol/ou4fx6
S. Liu, C. Chen, Q. Zheng, H. Sun, C. Yang, B. Wang, G. Shi, D. Xu, M. Shen
DOI: https://doi.org/10.55563/clinexprheumatol/ou4fx6
CER18246
2024,42,12
Pg. 2507-2512
Free to view
The clinical phenotype of isolated ocular or oral dryness in Sjögren’s disease
L.G. Chatzis, A.V. Goules, C. Baldini, V.C. Pezoulas, A.I. Venetsanopoulou, P.V. Voulgari, D.I. Fotiadis, F.N. Skopouli, H.M. Moutsopoulos, A.G. Tzioufas
DOI: https://doi.org/10.55563/clinexprheumatol/pcujhk
L.G. Chatzis, A.V. Goules, C. Baldini, V.C. Pezoulas, A.I. Venetsanopoulou, P.V. Voulgari, D.I. Fotiadis, F.N. Skopouli, H.M. Moutsopoulos, A.G. Tzioufas
DOI: https://doi.org/10.55563/clinexprheumatol/pcujhk
Reviews
CER17182
2024,42,12
Pg. 2513-2519
Free to view
Role of TLR7 in the pathogenesis of primary Sjögren's syndrome
Y. Song, W. Zhou
DOI: https://doi.org/10.55563/clinexprheumatol/cmmkod
Y. Song, W. Zhou
DOI: https://doi.org/10.55563/clinexprheumatol/cmmkod
CER17918
2024,42,12
Pg. 2520-2530
Free to view
Clinical utility of salivary and lacrimal gland ultrasonography in primary Sjögren’s syndrome
S.H. Kim, H.K. Min
DOI: https://doi.org/10.55563/clinexprheumatol/4rs4rs
S.H. Kim, H.K. Min
DOI: https://doi.org/10.55563/clinexprheumatol/4rs4rs
CER18248
2024,42,12
Pg. 2531-2541
Free to view
Infections in Sjögren's disease: a clinical concern or not?
P. Palla, L.G. Chatzis, N.V. Sipsas, A.V. Goules, A.G. Tzioufas
DOI: https://doi.org/10.55563/clinexprheumatol/ekder7
P. Palla, L.G. Chatzis, N.V. Sipsas, A.V. Goules, A.G. Tzioufas
DOI: https://doi.org/10.55563/clinexprheumatol/ekder7
Letters to the Editor
CER17626
2024,42,12
Pg. 2542
Free to view
Periodontal problems are not prevalent in Sjögren’s disease
A. Vissink, F. Maarse, D.H.J. Jager
DOI: https://doi.org/10.55563/clinexprheumatol/gymjl1
A. Vissink, F. Maarse, D.H.J. Jager
DOI: https://doi.org/10.55563/clinexprheumatol/gymjl1
CER17707
2024,42,12
Pg. 2543
Free to view
Reply to: Periodontal problems are not prevalent in Sjögren’s disease
G.A. Martínez-Nava, C. Hernández-Hernández, V. Ruiz-González, L. Llorente, G. Hernández-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/rmyoyk
G.A. Martínez-Nava, C. Hernández-Hernández, V. Ruiz-González, L. Llorente, G. Hernández-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/rmyoyk
CER17832
2024,42,12
Pg. 2544-2545
Free to view
Standardisation of the term “anti-Ro/SSA” in patients with Sjögren’s disease and other disorders
A.Y. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/ys8gtf
A.Y. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/ys8gtf
CER17953
2024,42,12
Pg. 2546
Free to view
Comment on: Standardisation of the term “anti-Ro/SSA” in patients with Sjögren’s disease and other disorders
E. Ben-Chetrit
DOI: https://doi.org/10.55563/clinexprheumatol/oi9ndh
E. Ben-Chetrit
DOI: https://doi.org/10.55563/clinexprheumatol/oi9ndh
CER17917
2024,42,12
Pg. 2547-2548
Free to view
A case of Sjögren’s syndrome presenting with conjunctival lymphoma
G. Galoppini, C. Iannone, I. Suardi, G.A. Impalà, R.F. Caporali, N. Del Papa
DOI: https://doi.org/10.55563/clinexprheumatol/yrdkrt
G. Galoppini, C. Iannone, I. Suardi, G.A. Impalà, R.F. Caporali, N. Del Papa
DOI: https://doi.org/10.55563/clinexprheumatol/yrdkrt